Pharmaceutical
Botanical ingredients ready for your regulatory dossiers.
Every batch supplies with the full documentation expected by health authorities: cultivation data, CoA and GACP records.
Ready to integrate into Marketing Authorization dossiers without requalification.
What pharma demands from its biomass suppliers
A CDMO that integrates a botanical extract into a pharmaceutical formulation bears full documentation responsibility to health authorities. A Certificate of Analysis alone does not satisfy a Marketing Authorization dossier.
You need upstream data: certified variety, documented origin, batch-level cultivation records, harvest window, drying and processing parameters. Most botanical ingredient suppliers do not produce this data.
The result is requalification at every batch change. It means additional requests from authorities and longer regulatory timelines.
Horssol grows in a controlled, traceable environment from seed onward. Documentation is generated alongside production, not reconstructed after the fact.
Compliance
Standards we operate under
Our production process is structured around pharmaceutical and para-pharmaceutical standards.
Regulatory requirements are built into the cultivation protocol from day one, not retrofitted.
GMP
Post-harvest steps including drying, processing and packaging follow GMP requirements. Critical parameters are recorded at every stage.
GACP
The baseline standard for any plant-based biomass intended for pharmaceutical use. Certified variety, documented cultivation conditions, plot-level traceability, controlled harvest window.
CoA
Every delivered batch includes a full CoA: botanical identification, active marker assay, content screening
QA
Standardized procedures and quality assurance
Use cases
Why pharmaceutical manufacturers contact us
PHYTOTHERAPY CDMO - FRANCE
Disruption risk on an imported raw material
Your biomass supply depends on one or two non-EU suppliers.
A harvest variation, a logistics issue or a quality gap is enough to halt your production.
Horssol grows in Europe under controlled conditions, with year-round scheduled deliveries.
PHARMACEUTICAL LABORATORY - SWITZERLAND
Documented biomass for a new Marketing Authorization dossier
You are building the raw material section of a regulatory dossier and need biomass backed by full cultivation and analytical data.
Horssol provides structured documentation, ready for direct use by your CMC team or regulatory contractor.
BOTANICAL CONTRACT MANUFACTURER - BELGIUM
Batch-to-batch variability in active content
Active compound levels in your current biomass fluctuate with origin and season, which complicates extract standardization.
Controlled-environment production stabilizes the phytochemical profile batch after batch.
PHARMACEUTICAL GROUP - GERMANY
You need a specific phytochemical profile
You need a raw material with active marker content above what the market offers, or a profile tailored to a specific formulation.
Horssol can co-develop the cultivation protocol with your R&D team.
Looking for a botanical ingredient ?
Cosmetics
Nutraceuticals